P
PamGene
Biotech & Life Sciences · 's-Hertogenbosch, Netherlands · Founded 2000
Offering kinase activity & nuclear receptor solutions in academic research & pharma partnerships MoreLess
Provider of novel kinomics platform intended to focus on the measurement of protein activities, with applications in biomarkers for oncology and medicine. The company's platform offers an array of technology, currently focussing on kinases tyrosine and serine-threonine and nuclear receptors, and provides software tools for data analysis, enabling researchers to discover medicines that inhibit or modulate cellular kinases and kinase pathways. Keywords: Pharmaceuticals and Biotechnology, Biomarker Research, Functional Proteomics, Kinase Activity Measurement, Medical Data, Microarray Technology, Molecular Biology.
Talent graph
PamGene's talent
Source: Dealroom Talent Intelligence.
Investors
5 investors on PamGene's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where PamGene has talent and traffic
team presence
Market sentiment
What the market is saying about PamGene
An AI-synthesized read of the highest-engagement posts about PamGene on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See PamGene on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.